|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Restructuring and exit costs | |||||
| Impairment of assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Gain on sale of product line | |||||
| Interest expense | |||||
| Amortization of prepaid debt costs | |||||
| Other components of defined benefit plans, net | |||||
| Other income | |||||
| Foreign currency exchange loss, net | |||||
| Loss from continuing operations before income taxes | |||||
| Income tax provision (benefit) | |||||
| Loss from continuing operations | |||||
| Income from discontinued operations, net of income taxes | |||||
| Net loss | |||||
| Net income (loss) per share - basic and diluted: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Net loss per share - basic and diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic and diluted |
Loading...